<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial	</title>
	<atom:link href="https://ora-vax.com/press-releases/oramed-provides-update-on-oravax-oral-vaccine-maker-gets-irb-approval-for-clinical-trial/feed/" rel="self" type="application/rss+xml" />
	<link>https://ora-vax.com/press-releases/oramed-provides-update-on-oravax-oral-vaccine-maker-gets-irb-approval-for-clinical-trial/</link>
	<description>Oravax is developing breakthrough technologies for the oral delivery of vaccines</description>
	<lastBuildDate>Thu, 07 Oct 2021 06:08:20 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.9.9</generator>
</channel>
</rss>
